Asia Leaders
Demis Hassabis Raised $2.1 Billion to Industrialise AI Drug Design. The Clinic Has Yet to Validate the Engine
Demis Hassabis has given Isomorphic Labs the capital and computing ambition of a technology platform. The harder test is whether its drug candidates can survive the slower economics of human biology.